Ankylosing spondylitis (AS) is a chronic, inflammatory rheumatic disease that mainly affects the axial skeleton, especially the sacroiliac joints and spine. Over time, persistent inflammation can lead to new bone formation, spinal stiffness, and eventual fusion of vertebrae.
What happens in ankylosing spondylitis
Inflammation starts at entheses (sites where ligaments and tendons attach to bone)
Recurrent inflammation causes pain and stiffness
Healing occurs with abnormal bone formation, leading to ankylosis (fusion)
Key clinical features
Inflammatory low back pain
Onset before 40 years
Insidious onset
Morning stiffness lasting more than 30 minutes
Improves with exercise, not with rest
Reduced spinal mobility
Chest expansion reduced
Peripheral arthritis (hips, shoulders)
Extra-articular features:
Acute anterior uveitis
Aortitis and aortic regurgitation (rare)
Apical lung fibrosis (late)
Etiology and risk factors
Strong genetic association with HLA-B27
More common in young males
Family history increases risk
Pathology (brief)
Sacroiliitis is the earliest lesion
Inflammation → erosion → sclerosis → ankylosis
Formation of syndesmophytes leads to a bamboo spine
Investigations
X-ray pelvis: bilateral sacroiliitis (late finding)
MRI: detects early inflammatory changes
Raised ESR and CRP
HLA-B27 positive in many patients (not diagnostic alone)
Management (overview)
Patient education and regular exercise
NSAIDs are first-line drugs
Biologic agents (TNF-α inhibitors, IL-17 inhibitors) in resistant cases
Posture training and physiotherapy are essential
Why it is important
Untreated ankylosing spondylitis can lead to severe spinal deformity, functional limitation, and reduced quality of life. Early diagnosis and treatment significantly improve outcomes.

Comments
Post a Comment